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Abstract
Objective: Previous studies reported that the clinical signif-
icance of intra-amniotic inflammation with a negative amni-
otic fluid (AF) culture is similar to that of intra-amniotic
inflammation with microbiologically-proven AF infection.
However, the magnitude of the fetal inflammatory response
in these two conditions is different as gauged by umbilical
cord C-reactive protein (CRP) concentrations. We undertook
this study to determine if the frequency of oligohydramnios
is different in these two conditions.
Methods: The amniotic fluid index (AFI) was measured in
205 patients with preterm premature rupture of membranes
(PROM) (F35 weeks). AF was cultured for aerobic and
anaerobic bacteria and genital mycoplasmas. Intra-amniotic
inflammation was defined as an elevated AF matrix metal-
loproteinase-8 (MMP-8) concentration ()23 ng/mL).
Patients were divided into three groups according to the
results of AF culture and the presence or absence of intra-
amniotic inflammation: 1) without intra-amniotic inflamma-
tion and a negative culture (ns109); 2) with intra-amniotic
inflammation and a negative culture (ns44); and 3) a pos-
itive culture (ns52).
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Results: Patients with a positive culture had a higher fre-
quency of oligohydramnios and a lower median AFI than
those with a negative culture but with intra-amniotic inflam-
mation (P-0.01). However, there was no significant differ-
ence in the median AFI or in the frequency of oligo-
hydramnios according to the presence or absence of intra-
amniotic inflammation among patients with a negative cul-
ture (P)0.1).
Conclusion: Oligohydramnios was more frequent in patients
with culture-proven AF infection than in those with intra-
amniotic inflammation and a negative AF culture.
Keywords: Amniotic fluid index (AFI); amniotic fluid infec-
tion; fetal inflammatory response syndrome (FIRS); intra-
amniotic inflammation; oligohydramnios; rupture of
membranes.
Introduction
Microbial invasion of the amniotic cavity is present in one
third of patients with preterm premature rupture of mem-
branes (PROM) and is strongly associated with impending
preterm delivery, adverse pregnancy and neonatal outcome
w4, 24, 25x. Previous studies have reported that the clinical
significance of intra-amniotic inflammation with a negative
culture for microorganisms is similar to that of microbiolog-
ically-proven amniotic fluid (AF) infection w25, 33x. How-
ever, proven AF infection, which is severe enough to yield
a positive culture, may reflect a higher microbial burden and
elicit a more intense fetal inflammatory response than intra-
amniotic inflammation with a negative culture. A previous
study documented that fetuses born to mothers with culture-
proven AF infection had a higher umbilical cord plasma C-
reactive protein (CRP) than those born to mothers with
culture-negative intra-amniotic inflammation w10x. This
could have different implications for fetal target organs,
including the kidney.
Oligohydramnios is frequently present in preterm PROM
w18, 27, 29x. Though the reduced AF volume is partly attrib-
uted to the escape of fluid through the site of membrane
rupture, microbial invasion of the amniotic cavity and the
subsequent fetal inflammatory response syndrome (FIRS) is
known to be associated with oligohydramnios, which has
been attributed to decreased fetal urine production w18, 30x.
The purpose of this study was to determine if proven AF
infection is associated with changes in AF volume.
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Materials and methods
Study design
The relationship between AF volume and intra-amniotic inflam-
mation and/or AF infection was examined in 205 singleton preg-
nancies admitted to our university hospital with the diagnosis of
preterm PROM who met the following criteria: (1) preterm preg-
nancy wgestational age (GA) F35 weeksx; (2) AF obtained for
microbiologic studies by transabdominal amniocentesis or at the
time of cesarean delivery; and (3) amniotic fluid index (AFI) deter-
mined before AF retrieval according to the method described by
Phelan et al. w19x. Oligohydramnios was defined as AFIF5 cm.
Patients were divided into three groups according to the presence
or absence of intra-amniotic inflammation and AF culture results:
Group 1: patients without inflammation, without infection (a neg-
ative AF culture; ns109); Group 2: patients with intra-amniotic
inflammation, without infection (a negative AF culture; ns44); and
Group 3: patients with a positive AF culture (ns52). Retrieval of
AF was performed after written informed consent was obtained. The
Institutional Review Board of the participating institution approved
the collection and use of these samples and information for research
purposes.
AF studies
AF was cultured for aerobic and anaerobic bacteria, as well as gen-
ital mycoplasmas (Mycoplasma hominis and Ureaplasma urealyti-
cum). An aliquot of AF was transported to the laboratory and
examined in a hemocytometer chamber to determine the white blood
cell (WBC) count. The remaining fluid was centrifuged and stored
in polypropylene tubes at –708C. Matrix metalloproteinase-8
(MMP-8) concentration was measured with a commercially availa-
ble enzyme-linked immunosorbent assay (Amersham Pharmacia
Biotech, Inc, Bucks, UK). The sensitivity of the test was 0.3
ng/mL. Intra- and inter-assay coefficients of variation were -10%,
respectively. MMP-8 was used to assess the presence of intra-amni-
otic inflammation because previous studies indicated that it is a
sensitive and specific index of inflammation w1, 12, 17x. Intra-amni-
otic inflammation was defined as an elevated AF MMP-8 concen-
tration ()23 ng/mL), as previously reported w17x.
Diagnosis of chorioamnionitis
Clinical chorioamnionitis was diagnosed in the presence of maternal
temperature of G37.88C and two or more of the following criteria:
(1) uterine tenderness; (2) malodorous vaginal discharge; (3) mater-
nal leukocytosis (WBC count of )15,000 cells/mm3); (4) maternal
tachycardia ()100 beats/min); and (5) fetal tachycardia ()160
beats/min) w3x. Acute histologic chorioamnionitis was diagnosed if
acute inflammatory changes were present on examination of the
extra-placental membranes or the chorionic plate of the placenta,
according to criteria previously published w31x. Funisitis was diag-
nosed in the presence of neutrophil infiltration into the umbilical
vessel walls or into Wharton’s jelly.
Statistical analysis
Proportions were compared with the Fisher’s exact test. A Kruskal-
Wallis analysis of variance test was used for comparison of contin-
uous variables among groups. Multiple comparisons between groups
were performed with the Mann-Whitney U-test. The amniocentesis-
to-delivery interval was compared using the generalized Wilcoxon
test for survival analysis. The interval-to-delivery of patients deliv-
ered for maternal or fetal indications was treated as a censored
observation, with a censoring time equal to the amniocentesis-to-
delivery interval. A P-0.05 was considered significant.
Results
The frequency of oligohydramnios (AFI F5 cm) was 29%
(59/205). The prevalence of a positive AF culture was 25%
(52/205). Microorganisms isolated from the AF included
Ureaplasma urealyticum (ns37), Candida species (ns4),
Streptococcus species (ns4), Escherichia coli (ns3), coag-
ulase-negative Staphylococcus (ns3), Mycoplasma hominis
(ns3), and one isolate each of Peptostreptococcus species,
Corynebacterium species, Acinatobacter baumanii, Burkhol-
deria cepalia, Staphylococcus hominis, and Staphylococcus
epidermidis. Six patients had polymicrobial infections (4
patients with 2 species, and 2 patients with 3 species of
microorganisms).
Table 1 describes the clinical characteristics and pregnancy
outcomes of the study population according to the results of
AF culture and MMP-8 concentrations. Patients with intra-
amniotic inflammation but a negative AF culture (Group 2)
had a significantly lower median GA at delivery, and birth
weight, and a higher rate of histologic chorioamnionitis and
funisitis than those without intra-amniotic inflammation and
a negative AF culture (Group 1). However, there was no
significant difference in the frequency of oligohydramnios
between groups 1 and 2 (26% vs. 16%; Ps0.2).
There were no significant differences in the clinical char-
acteristics and pregnancy outcomes between patients with
intra-amniotic inflammation and a negative AF culture
(Group 2) and those with a positive AF culture (Group 3),
except for the frequency of oligohydramnios, which was
higher in group 3 than in group 2 (46% vs. 16%; P-0.005).
Figure 1 shows that patients with a positive AF culture
had a lower median AFI than those with a negative culture
but with intra-amniotic inflammation (median, 5.1 wrange
0–17.5x vs. median 8.4 wrange 0–21.9x; P-0.01). However,
there was no significant difference in the median AFI accord-
ing to the presence or absence of intra-amniotic inflammation
in patients with a negative AF culture (median, 8.1 wrange
0–31.0x vs. median 8.4 wrange 0–21.9x; Ps0.8).
Forty-six percent (24/52) of patients with a positive AF
culture had oligohydramnios. Among patients with a positive
AF culture, the median GA at amniocentesis and delivery,
birth weight, and WBC count in AF, and the frequency of
clinical chorioamnionitis (29% vs. 11%), histologic cho-
rioamnionitis (100% vs. 78%), and funisitis (77% vs. 74%)
were not significantly different in patients with or without
oligohydramnios. However, patients with oligohydramnios
had a shorter interval-to-delivery than those without oligo-
hydramnios (median, 38 h wrange 0–285 hx vs. median 95 h
wrange 7–748 hx; P-0.001, Figure 2).
Cox proportional hazards model analysis indicated that the
presence of oligohydramnios (AFI F5 cm) was an inde-
pendent predictor of the interval-to-delivery after adjustment
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Table 1 Clinical characteristics and pregnancy outcomes of the study population according to the results of AF culture and MMP-8
concentrations.
(–) AF culture Pa (–) AF culture Pb (q) AF culture Pc
Low MMP-8 High MMP-8 (group 3; ns52)
(group 1; ns109) (group 2; ns44)
Maternal age (years) 30 (20–41) NS 31 (23–43) NS 29 (21–43) NS
Nulliparity (n) 57 (52%) NS 19 (43%) NS 22 (42%) NS
GA at amniocentesis (week)d 33.1 (20.4–35.0) -0.001 30.6 (21.7–34.9) NS 30.8 (22.4–34.7) -0.001
GA at delivery (week)d 34.7 (25.0–41.6) -0.001 31.4 (22.3–35.0) NS 31.5 (23.1–34.9) -0.001
Birth weight (g)d 2330 (660–4390) -0.001 1680 (520–2630) NS 1625 (570–2410) -0.001
Amniocentesis-to-delivery interval (h)d 127.8 (2.2–3544.5) -0.001 47.0 (0–881.5) NS 84.9 (0.2–748.4) -0.001
Preterm delivery (n)
Within 36 weeks 90 (83%) -0.005 44 (100%) (–) 52 (100%) -0.001
Within 34 weeks 32 (29%) -0.001 36 (82%) NS 44 (85%) -0.001
Clinical chorioamnionitis 2 (2%) NS 3 (7%) NS 10 (19%) 0.001
Histologic chorioamnionitis (n/N) 41/95 (43%) -0.001 30/34 (88%) NS 38/44 (86%) -0.001
Histologic chorioamnionitis; 5/16 (31%) -0.005 14/15 (93%) NS 16/18 (89%) -0.005
delivered F48 he
Funisitis (n/N) 18/95 (19%) -0.001 21/34 (62%) NS 33/44 (75%) -0.001
Funisitis; 1/16 (6%) -0.005 9/15 (60%) NS 14/18 (78%) -0.001
delivered F48 he
AF WBC (cells/mm3)d 1 (0–243) -0.001 414 (0–)1000) NS 314 (0–)1000) -0.001
AF MMP-8 (ng/mL)d 1.4 (0.3–22.3) -0.001 184.4 (24.9–2874.5) NS 255.6 (0.4–2370.6) -0.001
Oligohydramnios (AFIF5) 28 (26%) NS 7 (16%) -0.005 24 (46%) -0.05
Values are medians and ranges.
aComparison between groups 1 and 2.
bComparison between groups 2 and 3.
cComparison between groups 3 and 1.
dP-0.05 by Kruskal-Wallis ANOVA test.
eTo preserve a meaningful temporal relationship between the results of AF studies and histologic findings of the placenta obtained at delivery,
cases delivered within 48 h of amniocentesis were considered for the analysis.
AFsamniotic fluid, MMP-8smatrix metalloproteinase-8, Low MMP-8smatrix metalloproteinase-8 -23 ng/mL, High MMP-8smatrix
metalloproteinase-8 )23 ng/mL, GAsgestational age, NSsnot significant, WBCswhite blood cell, AFIsamniotic fluid index.
Figure 1 Amniotic fluid index (AFI) according to the presence or
absence of intra-amniotic inflammation and AF culture results: the
median AFI in patients with intra-amniotic inflammation and a neg-
ative AF culture was significantly higher than that in patients with
a positive AF culture, but was not different from that in patients
without intra-amniotic inflammation and with a negative AF culture.
for GA and the AF culture results whazards ratio (HR), 1.8;
95% Confidence interval (CI), (1.3–2.6)x.
Comment
Principal findings of this study
1) Oligohydramnios is associated with microbiologically-
proven AF infection; 2) among cases with proven AF
infection, those with oligohydramnios had a shorter amnio-
centesis-to-delivery interval than those with an AFI )5 cm.
AF infection, FIRS and oligohydramnios
Oligohydramnios is often associated with microbial invasion
of the amniotic cavity w18, 27–30x. Microorganisms in the
AF can gain access to the fetus and elicit a systemic FIRS
w5, 23, 26x. Pro-inflammatory cytokines released during FIRS
can have effects on multiple fetal organ systems such as the
brain and heart, leading to blood flow redistribution and car-
diac dysfunction w22, 30, 34x. Reduction of renal blood flow
during FIRS can result in the decrease of fetal urine produc-
tion and the subsequent oligohydramnios. Indeed, a previous
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Figure 2 Survival analysis of interval-to-delivery among patients
with preterm premature rupture of membranes and amniotic fluid
infection according to the presence or absence of oligohydramnios
(median, 38 h; range, 0–285 h vs. median, 95 h; range, 7–748 h;
P-0.001).
study indicated that umbilical cord plasma concentrations of
interleukin-6, which is the hallmark of FIRS, are signifi-
cantly elevated in fetuses with oligohydramnios and preterm
PROM compared with those without oligohydramnios w30x.
Therefore, there is solid evidence linking microbial invasion
of the amniotic cavity, FIRS and oligohydramnios.
Intra-amniotic inflammation in the absence
of proven AF infection
A novel finding of this study is that among patients with
intra-amniotic inflammation, those with proven AF infection
had a decreased AF volume, whereas those with a negative
AF culture did not. Substantial evidence indicates that intra-
amniotic inflammation is a risk factor for adverse pregnancy
and neonatal outcome, regardless of the presence or absence
of a positive AF culture w2, 7–9, 16, 25, 33, 34x. However,
the data presented herein demonstrate that a culture-proven
infection has clinical implications beyond the presence of
intra-amniotic inflammation with a negative AF culture in
preterm PROM. This finding suggests that FIRS, in cases
with intra-amniotic inflammation with a negative culture,
may be milder than the one associated with a positive AF
culture. Milder cases of FIRS may not be severe enough to
cause a reduction of fetal urine production, which appears to
occur in cases with proven AF infection and more severe
FIRS. Indeed, studies in adults indicate that there is disease
progression which begins with a systemic inflammatory
response and advances to sepsis, severe sepsis and septic
shock w11, 20x.
We propose that fetuses with a positive AF culture have
a more severe systemic inflammatory response compared to
those with intra-amniotic inflammation with a negative cul-
ture. Support for this hypothesis is derived from a prior
report indicating that among patients with intra-amniotic
inflammation, those with proven infection had a higher con-
centration of umbilical cord plasma CRP than those with a
negative AF culture w10x.
Intensity of FIRS
This study suggests that fetuses with positive AF cultures
have a greater degree of systemic fetal inflammation com-
pared to those with intra-amniotic inflammation and negative
AF cultures. Why the difference? Intra-amniotic inflamma-
tion in the absence of proven AF infection is commonly con-
sidered to be attributed to infection in which organisms
escaped detection by traditional microbiological methods
w15, 32x. It is possible that the microbial burden of patients
with a positive culture is greater than that of those with a
negative culture. Small inoculum size of microorganisms
probably contributed to the failure of cultivation. It is also
possible that microorganisms recovered with culture tech-
niques may be more virulent than those who resist cultivation
in the laboratory.
FIRS in proven AF infection
AF infection is associated with immune responses w6, 13,
21x, and FIRS has been also understood as an immune
response, which can signal the initiation of parturition for
the fetus to exit a hostile intrauterine environment w23x. Of
interest, our data showed that among cases with proven AF
infection, patients with oligohydramnios had an increased
risk for impending delivery compared to those with normal
AF volume. This suggests that fetuses with oligohydramnios
in the presence of proven AF infection probably have an
advanced stage of FIRS. However, this cannot be addressed
with current data because the difference in the magnitude of
FIRS between cases with and without oligohydramnios was
not examined. Such issue requires a large cohort consisting
of fetuses whose umbilical cord blood was retrieved at the
time of AFI determination.
Unanswered questions, limitations and further
considerations
Further studies are required to determine if oligohydramnios
in the presence of proven AF culture is associated with a
worse neonatal outcome. This question cannot be addressed
with the sample size in this study.
Clinical implication in this study
This investigation indicated that oligohydramnios is associ-
ated with microbiologically proven AF infection, and that
among cases with proven AF infection, patients with oligo-
hydramnios had an increased risk for impending delivery
compared with those with a normal AFI. Indeed, several
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studies have reported a higher frequency of sepsis in neo-
nates born to mothers with oligohydramnios w14, 28–30x.
Therefore, we propose that the presence of oligohydramnios
combined with the results of AF culture should be considered
when planning the management of patients presenting pre-
term PROM.
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